0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.76%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
1.59%
Positive gross profit growth while ANO.AX is negative. John Neff would see a clear operational edge over the competitor.
59.24%
Positive EBIT growth while ANO.AX is negative. John Neff might see a substantial edge in operational management.
59.24%
Positive operating income growth while ANO.AX is negative. John Neff might view this as a competitive edge in operations.
-96.52%
Negative net income growth while ANO.AX stands at 12.95%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.93%
Share reduction more than 1.5x ANO.AX's 124.15%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.93%
Diluted share reduction more than 1.5x ANO.AX's 124.15%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
97.84%
OCF growth of 97.84% while ANO.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
69.41%
Positive FCF growth while ANO.AX is negative. John Neff would see a strong competitive edge in net cash generation.
-90.53%
Negative 10Y revenue/share CAGR while ANO.AX stands at 32.63%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-56.69%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-57.18%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.04%
Negative 10Y OCF/share CAGR while ANO.AX stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
99.83%
OCF/share CAGR of 99.83% while ANO.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-100.40%
Negative 3Y OCF/share CAGR while ANO.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-99.95%
Negative 10Y net income/share CAGR while ANO.AX is at 83.83%. Joel Greenblatt sees a major red flag in long-term profit erosion.
100.07%
5Y net income/share CAGR 1.25-1.5x ANO.AX's 84.74%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
100.31%
Positive short-term CAGR while ANO.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.30%
R&D dropping or stable vs. ANO.AX's 5711.71%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-15.35%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.